Gilead Sciences
GILD
#131
Rank
A$222.87 B
Marketcap
A$179.62
Share price
-1.51%
Change (1 day)
29.78%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): A$15.32 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.08 Billion. In 2024 the company made an earning of A$1.03 Billion a decrease over its 2023 earnings that were of A$10.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$15.32 B1375.96%
2024 A$1.03 B-89.94%
2023 A$10.32 B17.97%
2022 A$8.74 B-29.77%
2021 A$12.45 B395.99%
2020 A$2.51 B-67.66%
2019 A$7.76 B-33.84%
2018 A$11.73 B-42.35%
2017 A$20.35 B-20.87%
2016 A$25.72 B-21.06%
2015 A$32.59 B45.8%
2014 A$22.35 B253.01%
2013 A$6.33 B16.51%
2012 A$5.43 B-1.07%
2011 A$5.49 B-6.71%
2010 A$5.88 B11.75%
2009 A$5.27 B29.5%
2008 A$4.06 B19.11%
2007 A$3.41 B-455.74%
2006 -A$0.97 Billion-154.93%
2005 A$1.74 B76.99%
2004 A$0.98 B-266.16%
2003 -A$0.6 Billion-638.24%
2002 A$0.11 B31.5%
2001 A$83.99 M-242.15%
2000 -A$59.1 Million-40.2%
1999 -A$98.82 Million31.85%
1998 -A$74.95 Million8.73%
1997 -A$68.93 Million27.22%
1996 -A$54.18 Million
1994 -A$51.62 Million26.57%
1993 -A$40.79 Million46.49%
1992 -A$27.85 Million362.5%
1991 -A$6.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.40 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.71 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.49 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.49 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.86 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.83 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.75 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.86 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.74 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA